ArticleHead and neck pathology2026
Malignant Transformation of a Radiation-Naïve Sinonasal Tract Angiofibroma: Clinicopathologic and Molecular Characterization of an Exceptionally Delayed Transformation.
Article in Head and neck pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sinonasal tract angiofibroma (formerly juvenile nasopharyngeal angiofibroma) is a rare benign but locally aggressive vascular tumor that predominantly affects adolescent males. Malignant transformation is exceedingly uncommon and has historically been reported following radiation therapy, with only two cases described in radiation-naïve patients. We report a 56-year-old male with a history of sinonasal tract angiofibroma diagnosed at age 11 and recurrent at age 54, who developed sarcomatous transformation more than four decades after the initial diagnosis and just two years after developing a first overtly non-sarcomatous recurrence. The most recent surgical resection and histopathologic evaluation demonstrated a hypercellular, spindle cell proliferation with hyperchromasia, conspicuous mitoses and a herringbone architectural pattern distinct from angiofibroma. Molecular analysis revealed a shared CTNNB1 variant and TERT promoter mutation in both the recurrent angiofibroma and subsequent malignancy, with additional NRAS and STK11 alterations in the sarcoma, supporting clonal evolution. This case underscores the possibility for delayed recurrence and subsequent radiation- naïve malignant transformation, along with molecular mechanisms, and highlights the necessity for long-term clinical surveillance in patients with sinonasal tract angiofibroma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.